Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice
- 11 September 2002
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 9 (10) , 799-806
- https://doi.org/10.1038/sj.cgt.7700504
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Targeting Angiogenesis and HGF Function Using an Adenoviral Vector Expressing the HGF Antagonist NK4 for Cancer TherapyMolecular Therapy, 2002
- Kringle 1–4 of Hepatocyte Growth Factor Inhibits Proliferation and Migration of Human Microvascular Endothelial CellsBiochemical and Biophysical Research Communications, 2000
- The Use of Laser Scanning Cytometry to Assess Depth of Penetration of Adenovirus p53 Gene Therapy in Human Xenograft BiopsiesThe American Journal of Pathology, 1999
- Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancerCritical Reviews in Oncology/Hematology, 1999
- Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factorOncogene, 1998
- Cooperative Interaction between α- and β-Chains of Hepatocyte Growth Factor on c-Met Receptor Confers Ligand-induced Receptor Tyrosine Phosphorylation and Multiple Biological ResponsesJournal of Biological Chemistry, 1998
- Hepatocyte Growth Factor (HGF) as a Tissue Organizer for Organogenesis and RegenerationBiochemical and Biophysical Research Communications, 1997
- Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal disseminationInternational Journal of Cancer, 1996
- Pancreatic CarcinomaNew England Journal of Medicine, 1992
- Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized ratsBiochemical and Biophysical Research Communications, 1984